Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT299 | Individual Protein | Androgen Receptor | Rattus norvegicus | IC50 | = | 19054.61 | nM | 16134935 |
NPT137 | Cell Line | L1210 | Mus musculus | Activity | < | 15 | % | 16279782 |
NPT312 | Organism | Saccharomyces cerevisiae | Saccharomyces cerevisiae | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT347 | Cell Line | Lymphoblastoid cells | Homo sapiens | Potency | = | 25118.9 | nM | PubChem BioAssay data set |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 25929 | nM | PubChem BioAssay data set | |
NPT539 | Individual Protein | Cellular tumor antigen p53 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 29092.9 | nM | PubChem BioAssay data set | ||
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 9285 | nM | PubChem BioAssay data set | |
NPT46 | Individual Protein | Thyroid hormone receptor beta-1 | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT135 | Individual Protein | Chromobox protein homolog 1 | Homo sapiens | Potency | 89125.1 | nM | PubChem BioAssay data set | |
NPT249 | Individual Protein | Glucocorticoid receptor | Homo sapiens | Potency | 28183.8 | nM | PubChem BioAssay data set | |
NPT204 | Individual Protein | Acetylcholinesterase | Homo sapiens | IC50 | = | 11471 | nM | DrugMatrix in vitro pharmacology data |
NPT217 | Individual Protein | Adenosine A2a receptor | Homo sapiens | IC50 | = | 22432 | nM | DrugMatrix in vitro pharmacology data |
NPT217 | Individual Protein | Adenosine A2a receptor | Homo sapiens | Ki | = | 12593 | nM | DrugMatrix in vitro pharmacology data |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | IC50 | = | 6014 | nM | DrugMatrix in vitro pharmacology data |
NPT218 | Individual Protein | Adenosine A3 receptor | Homo sapiens | Ki | = | 3399 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | IC50 | = | 14288 | nM | DrugMatrix in vitro pharmacology data |
NPT222 | Individual Protein | Alpha-2a adrenergic receptor | Homo sapiens | Ki | = | 5358 | nM | DrugMatrix in vitro pharmacology data |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | IC50 | = | 12496 | nM | DrugMatrix in vitro pharmacology data |
NPT223 | Individual Protein | Alpha-2b adrenergic receptor | Homo sapiens | Ki | = | 5705 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | IC50 | = | 14234 | nM | DrugMatrix in vitro pharmacology data |
NPT224 | Individual Protein | Alpha-2c adrenergic receptor | Homo sapiens | Ki | = | 2068 | nM | DrugMatrix in vitro pharmacology data |
NPT228 | Individual Protein | Norepinephrine transporter | Homo sapiens | IC50 | = | 61647 | nM | DrugMatrix in vitro pharmacology data |
NPT228 | Individual Protein | Norepinephrine transporter | Homo sapiens | Ki | = | 61138 | nM | DrugMatrix in vitro pharmacology data |
NPT30 | Individual Protein | Cyclooxygenase-1 | Homo sapiens | IC50 | = | 10319 | nM | DrugMatrix in vitro pharmacology data |
NPT31 | Individual Protein | Cyclooxygenase-2 | Homo sapiens | IC50 | = | 2862 | nM | DrugMatrix in vitro pharmacology data |
NPT246 | Individual Protein | Dopamine transporter | Homo sapiens | IC50 | = | 8491 | nM | DrugMatrix in vitro pharmacology data |
NPT246 | Individual Protein | Dopamine transporter | Homo sapiens | Ki | = | 6746 | nM | DrugMatrix in vitro pharmacology data |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | IC50 | = | 27674 | nM | DrugMatrix in vitro pharmacology data |
NPT108 | Individual Protein | Estrogen receptor alpha | Homo sapiens | Ki | = | 7907 | nM | DrugMatrix in vitro pharmacology data |
NPT257 | Individual Protein | Arachidonate 15-lipoxygenase | Oryctolagus cuniculus | IC50 | = | 4093 | nM | DrugMatrix in vitro pharmacology data |
NPT262 | Individual Protein | Muscarinic acetylcholine receptor M1 | Homo sapiens | IC50 | = | 18013 | nM | DrugMatrix in vitro pharmacology data |
NPT262 | Individual Protein | Muscarinic acetylcholine receptor M1 | Homo sapiens | Ki | = | 4338 | nM | DrugMatrix in vitro pharmacology data |
NPT263 | Individual Protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | IC50 | = | 12466 | nM | DrugMatrix in vitro pharmacology data |
NPT263 | Individual Protein | Muscarinic acetylcholine receptor M2 | Homo sapiens | Ki | = | 4432 | nM | DrugMatrix in vitro pharmacology data |
NPT264 | Individual Protein | Muscarinic acetylcholine receptor M3 | Homo sapiens | IC50 | = | 19004 | nM | DrugMatrix in vitro pharmacology data |
NPT264 | Individual Protein | Muscarinic acetylcholine receptor M3 | Homo sapiens | Ki | = | 4028 | nM | DrugMatrix in vitro pharmacology data |
NPT266 | Individual Protein | Muscarinic acetylcholine receptor M5 | Homo sapiens | IC50 | = | 30764 | nM | DrugMatrix in vitro pharmacology data |
NPT266 | Individual Protein | Muscarinic acetylcholine receptor M5 | Homo sapiens | Ki | = | 22102 | nM | DrugMatrix in vitro pharmacology data |
NPT283 | Individual Protein | MAP kinase p38 alpha | Homo sapiens | IC50 | = | 15016 | nM | DrugMatrix in vitro pharmacology data |
NPT285 | Individual Protein | Epidermal growth factor receptor erbB1 | Homo sapiens | IC50 | = | 16219 | nM | DrugMatrix in vitro pharmacology data |
NPT13 | Individual Protein | Tyrosine-protein kinase LCK | Homo sapiens | IC50 | = | 22054 | nM | DrugMatrix in vitro pharmacology data |
NPT295 | Individual Protein | Serotonin transporter | Homo sapiens | IC50 | = | 6973 | nM | DrugMatrix in vitro pharmacology data |
NPT295 | Individual Protein | Serotonin transporter | Homo sapiens | Ki | = | 3704 | nM | DrugMatrix in vitro pharmacology data |
NPT298 | Individual Protein | Neurokinin 2 receptor | Homo sapiens | IC50 | = | 17430 | nM | DrugMatrix in vitro pharmacology data |
NPT298 | Individual Protein | Neurokinin 2 receptor | Homo sapiens | Ki | = | 5810 | nM | DrugMatrix in vitro pharmacology data |
NPT300 | Individual Protein | Thromboxane-A synthase | Homo sapiens | IC50 | = | 66049 | nM | DrugMatrix in vitro pharmacology data |
NPT484 | Individual Protein | Luciferin 4-monooxygenase | Photinus pyralis | Potency | 37207.9 | nM | PubChem BioAssay data set | |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 50118.7 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 42163.2 | nM | PubChem BioAssay data set | |
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 54482.7 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 37578 | nM | PubChem BioAssay data set | ||
NPT159 | Individual Protein | Aberrant vpr protein | Human immunodeficiency virus 1 | Potency | 63095.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 18356.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24336.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12995.3 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 18356.4 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 35481.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 19331.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19610.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 8759.8 | nM | PubChem BioAssay data set | ||
NPT161 | Individual Protein | Rap guanine nucleotide exchange factor 4 | Homo sapiens | Potency | 44668.4 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 11027.9 | nM | PubChem BioAssay data set | |
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 21822.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 9747.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21689.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 62014.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1102.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 68982 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3487.3 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 56234.1 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 54794.3 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 11 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 4885.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 61503.8 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 43903 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 62014.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 30637.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 1544.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 27472.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 34873.4 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 48557.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 1748 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 66824.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 49259.9 | nM | PubChem BioAssay data set | ||
NPT162 | Individual Protein | Heat shock protein beta-1 | Homo sapiens | Potency | 27700.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 2200.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 3108.5 | nM | PubChem BioAssay data set | ||
NPT153 | Individual Protein | Androgen Receptor | Homo sapiens | Potency | 6150.4 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 24485.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 9828.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12271.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 21822.4 | nM | PubChem BioAssay data set | ||
NPT106 | Individual Protein | Peroxisome proliferator-activated receptor delta | Homo sapiens | Potency | 48835.5 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 55270.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 24688.4 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 15449 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 54482.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 19449.2 | nM | PubChem BioAssay data set | ||
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | Potency | 17480.2 | nM | PubChem BioAssay data set | |
NPT74 | Individual Protein | Proto-oncogene c-JUN | Homo sapiens | Potency | 19610.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | 1412.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 12373.5 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 22003.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7742.9 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 48854.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | AC50 | 19952.6 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC318325 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC242240 |
1.0 | High Similarity | NPC123273 |
0.9881 | High Similarity | NPC25493 |
0.9881 | High Similarity | NPC113460 |
0.9765 | High Similarity | NPC280347 |
0.9765 | High Similarity | NPC177420 |
0.9765 | High Similarity | NPC258219 |
0.9762 | High Similarity | NPC23167 |
0.9651 | High Similarity | NPC55561 |
0.9643 | High Similarity | NPC197783 |
0.9545 | High Similarity | NPC316301 |
0.9545 | High Similarity | NPC27323 |
0.954 | High Similarity | NPC304541 |
0.9529 | High Similarity | NPC184169 |
0.9524 | High Similarity | NPC248817 |
0.9524 | High Similarity | NPC175313 |
0.9438 | High Similarity | NPC26244 |
0.9405 | High Similarity | NPC265146 |
0.9405 | High Similarity | NPC124436 |
0.9333 | High Similarity | NPC473388 |
0.9326 | High Similarity | NPC151715 |
0.9318 | High Similarity | NPC45040 |
0.9318 | High Similarity | NPC155908 |
0.9318 | High Similarity | NPC204210 |
0.931 | High Similarity | NPC98772 |
0.9302 | High Similarity | NPC407 |
0.9302 | High Similarity | NPC307235 |
0.9231 | High Similarity | NPC77492 |
0.9231 | High Similarity | NPC225464 |
0.9222 | High Similarity | NPC8392 |
0.9213 | High Similarity | NPC3358 |
0.9213 | High Similarity | NPC210497 |
0.9213 | High Similarity | NPC138117 |
0.9213 | High Similarity | NPC325292 |
0.9213 | High Similarity | NPC306884 |
0.9213 | High Similarity | NPC162314 |
0.9213 | High Similarity | NPC147284 |
0.9213 | High Similarity | NPC94139 |
0.9205 | High Similarity | NPC300017 |
0.9205 | High Similarity | NPC192 |
0.9195 | High Similarity | NPC27974 |
0.9186 | High Similarity | NPC155393 |
0.913 | High Similarity | NPC122005 |
0.913 | High Similarity | NPC252821 |
0.913 | High Similarity | NPC92730 |
0.913 | High Similarity | NPC128723 |
0.9111 | High Similarity | NPC152415 |
0.9111 | High Similarity | NPC128062 |
0.9101 | High Similarity | NPC306074 |
0.9101 | High Similarity | NPC270547 |
0.9091 | High Similarity | NPC70436 |
0.907 | High Similarity | NPC286904 |
0.9032 | High Similarity | NPC225506 |
0.9011 | High Similarity | NPC313650 |
0.9011 | High Similarity | NPC274678 |
0.9011 | High Similarity | NPC144682 |
0.9 | High Similarity | NPC55903 |
0.8977 | High Similarity | NPC104216 |
0.8925 | High Similarity | NPC51333 |
0.8925 | High Similarity | NPC78119 |
0.8925 | High Similarity | NPC216468 |
0.8925 | High Similarity | NPC132078 |
0.8913 | High Similarity | NPC132271 |
0.8913 | High Similarity | NPC82664 |
0.8913 | High Similarity | NPC292730 |
0.8913 | High Similarity | NPC216520 |
0.8901 | High Similarity | NPC289769 |
0.8901 | High Similarity | NPC76938 |
0.8851 | High Similarity | NPC150837 |
0.883 | High Similarity | NPC213730 |
0.883 | High Similarity | NPC211885 |
0.8817 | High Similarity | NPC6597 |
0.8817 | High Similarity | NPC260000 |
0.8817 | High Similarity | NPC474073 |
0.8817 | High Similarity | NPC79241 |
0.8804 | High Similarity | NPC222146 |
0.8804 | High Similarity | NPC32714 |
0.8791 | High Similarity | NPC271440 |
0.8791 | High Similarity | NPC181709 |
0.8778 | High Similarity | NPC300478 |
0.8764 | High Similarity | NPC19680 |
0.8737 | High Similarity | NPC40258 |
0.8737 | High Similarity | NPC7686 |
0.8737 | High Similarity | NPC91461 |
0.8723 | High Similarity | NPC80027 |
0.8723 | High Similarity | NPC299762 |
0.8723 | High Similarity | NPC33675 |
0.8723 | High Similarity | NPC280869 |
0.871 | High Similarity | NPC312132 |
0.871 | High Similarity | NPC259512 |
0.871 | High Similarity | NPC202986 |
0.8696 | High Similarity | NPC245187 |
0.8681 | High Similarity | NPC231150 |
0.866 | High Similarity | NPC154899 |
0.866 | High Similarity | NPC138942 |
0.866 | High Similarity | NPC233396 |
0.866 | High Similarity | NPC303141 |
0.8646 | High Similarity | NPC196479 |
0.8646 | High Similarity | NPC168829 |
0.8632 | High Similarity | NPC248396 |
0.8632 | High Similarity | NPC48730 |
0.8632 | High Similarity | NPC129373 |
0.8632 | High Similarity | NPC72729 |
0.8617 | High Similarity | NPC32674 |
0.8617 | High Similarity | NPC107619 |
0.8617 | High Similarity | NPC152097 |
0.8617 | High Similarity | NPC109955 |
0.8571 | High Similarity | NPC271274 |
0.8571 | High Similarity | NPC113457 |
0.8571 | High Similarity | NPC135464 |
0.8571 | High Similarity | NPC477814 |
0.8571 | High Similarity | NPC92623 |
0.8557 | High Similarity | NPC120719 |
0.8557 | High Similarity | NPC8931 |
0.8557 | High Similarity | NPC119860 |
0.8557 | High Similarity | NPC120693 |
0.8557 | High Similarity | NPC261573 |
0.8557 | High Similarity | NPC288411 |
0.8542 | High Similarity | NPC471578 |
0.8542 | High Similarity | NPC101025 |
0.8542 | High Similarity | NPC252105 |
0.8542 | High Similarity | NPC472585 |
0.8526 | High Similarity | NPC245561 |
0.8526 | High Similarity | NPC260775 |
0.8495 | Intermediate Similarity | NPC81010 |
0.8495 | Intermediate Similarity | NPC32977 |
0.8488 | Intermediate Similarity | NPC133050 |
0.8485 | Intermediate Similarity | NPC228737 |
0.8469 | Intermediate Similarity | NPC474839 |
0.8469 | Intermediate Similarity | NPC243677 |
0.8454 | Intermediate Similarity | NPC235762 |
0.8454 | Intermediate Similarity | NPC313030 |
0.8454 | Intermediate Similarity | NPC471228 |
0.8454 | Intermediate Similarity | NPC106396 |
0.8454 | Intermediate Similarity | NPC71002 |
0.8454 | Intermediate Similarity | NPC62351 |
0.8454 | Intermediate Similarity | NPC108497 |
0.8454 | Intermediate Similarity | NPC242342 |
0.8454 | Intermediate Similarity | NPC222522 |
0.8454 | Intermediate Similarity | NPC94351 |
0.8454 | Intermediate Similarity | NPC302219 |
0.8454 | Intermediate Similarity | NPC85479 |
0.8454 | Intermediate Similarity | NPC146798 |
0.8454 | Intermediate Similarity | NPC470202 |
0.8454 | Intermediate Similarity | NPC53051 |
0.8454 | Intermediate Similarity | NPC168303 |
0.8454 | Intermediate Similarity | NPC249828 |
0.8454 | Intermediate Similarity | NPC135784 |
0.8454 | Intermediate Similarity | NPC24404 |
0.8438 | Intermediate Similarity | NPC289381 |
0.8438 | Intermediate Similarity | NPC10588 |
0.8438 | Intermediate Similarity | NPC130756 |
0.8438 | Intermediate Similarity | NPC174911 |
0.8438 | Intermediate Similarity | NPC294741 |
0.8438 | Intermediate Similarity | NPC12931 |
0.8438 | Intermediate Similarity | NPC52472 |
0.8438 | Intermediate Similarity | NPC166761 |
0.8438 | Intermediate Similarity | NPC155847 |
0.8438 | Intermediate Similarity | NPC70677 |
0.8421 | Intermediate Similarity | NPC201967 |
0.8421 | Intermediate Similarity | NPC475078 |
0.8409 | Intermediate Similarity | NPC304538 |
0.8404 | Intermediate Similarity | NPC286006 |
0.8404 | Intermediate Similarity | NPC107522 |
0.84 | Intermediate Similarity | NPC75440 |
0.84 | Intermediate Similarity | NPC61885 |
0.84 | Intermediate Similarity | NPC317305 |
0.84 | Intermediate Similarity | NPC63698 |
0.84 | Intermediate Similarity | NPC11554 |
0.8387 | Intermediate Similarity | NPC29373 |
0.8384 | Intermediate Similarity | NPC188677 |
0.8384 | Intermediate Similarity | NPC21594 |
0.837 | Intermediate Similarity | NPC151764 |
0.837 | Intermediate Similarity | NPC47950 |
0.837 | Intermediate Similarity | NPC312304 |
0.8367 | Intermediate Similarity | NPC254965 |
0.8367 | Intermediate Similarity | NPC471511 |
0.8367 | Intermediate Similarity | NPC327811 |
0.8367 | Intermediate Similarity | NPC30506 |
0.8367 | Intermediate Similarity | NPC475225 |
0.8351 | Intermediate Similarity | NPC110764 |
0.8351 | Intermediate Similarity | NPC72947 |
0.8351 | Intermediate Similarity | NPC137415 |
0.8351 | Intermediate Similarity | NPC166313 |
0.8351 | Intermediate Similarity | NPC147310 |
0.8351 | Intermediate Similarity | NPC284011 |
0.8351 | Intermediate Similarity | NPC294186 |
0.8351 | Intermediate Similarity | NPC24407 |
0.8351 | Intermediate Similarity | NPC11280 |
0.8351 | Intermediate Similarity | NPC477685 |
0.8351 | Intermediate Similarity | NPC51015 |
0.8351 | Intermediate Similarity | NPC192032 |
0.8333 | Intermediate Similarity | NPC130193 |
0.8333 | Intermediate Similarity | NPC100870 |
0.8333 | Intermediate Similarity | NPC171843 |
0.8333 | Intermediate Similarity | NPC125732 |
0.8317 | Intermediate Similarity | NPC75272 |
0.8317 | Intermediate Similarity | NPC471954 |
0.8317 | Intermediate Similarity | NPC254833 |
0.8317 | Intermediate Similarity | NPC95172 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC318325 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9545 | High Similarity | NPD1432 | Clinical (unspecified phase) |
0.9438 | High Similarity | NPD2860 | Approved |
0.9438 | High Similarity | NPD2859 | Approved |
0.9405 | High Similarity | NPD111 | Approved |
0.9326 | High Similarity | NPD2933 | Approved |
0.9326 | High Similarity | NPD2934 | Approved |
0.913 | High Similarity | NPD3020 | Approved |
0.9011 | High Similarity | NPD844 | Approved |
0.9011 | High Similarity | NPD1809 | Phase 2 |
0.9 | High Similarity | NPD845 | Approved |
0.8936 | High Similarity | NPD940 | Approved |
0.8936 | High Similarity | NPD846 | Approved |
0.871 | High Similarity | NPD288 | Approved |
0.8438 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.8367 | Intermediate Similarity | NPD9608 | Approved |
0.8367 | Intermediate Similarity | NPD9610 | Approved |
0.8317 | Intermediate Similarity | NPD3022 | Approved |
0.8317 | Intermediate Similarity | NPD3021 | Approved |
0.82 | Intermediate Similarity | NPD1445 | Approved |
0.82 | Intermediate Similarity | NPD1444 | Approved |
0.8095 | Intermediate Similarity | NPD9087 | Approved |
0.8061 | Intermediate Similarity | NPD1242 | Phase 1 |
0.8061 | Intermediate Similarity | NPD3028 | Approved |
0.8 | Intermediate Similarity | NPD2228 | Approved |
0.8 | Intermediate Similarity | NPD2234 | Approved |
0.8 | Intermediate Similarity | NPD2229 | Approved |
0.7961 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7864 | Intermediate Similarity | NPD2684 | Approved |
0.7816 | Intermediate Similarity | NPD9294 | Approved |
0.781 | Intermediate Similarity | NPD228 | Approved |
0.781 | Intermediate Similarity | NPD6124 | Clinical (unspecified phase) |
0.7788 | Intermediate Similarity | NPD9380 | Clinical (unspecified phase) |
0.7788 | Intermediate Similarity | NPD4750 | Phase 3 |
0.7727 | Intermediate Similarity | NPD9088 | Approved |
0.7723 | Intermediate Similarity | NPD9500 | Approved |
0.7685 | Intermediate Similarity | NPD255 | Approved |
0.7685 | Intermediate Similarity | NPD256 | Approved |
0.7677 | Intermediate Similarity | NPD9273 | Approved |
0.7664 | Intermediate Similarity | NPD7159 | Clinical (unspecified phase) |
0.7636 | Intermediate Similarity | NPD5303 | Approved |
0.7636 | Intermediate Similarity | NPD5304 | Approved |
0.7636 | Intermediate Similarity | NPD3091 | Approved |
0.7596 | Intermediate Similarity | NPD2342 | Discontinued |
0.7593 | Intermediate Similarity | NPD1793 | Approved |
0.7593 | Intermediate Similarity | NPD1791 | Approved |
0.757 | Intermediate Similarity | NPD821 | Approved |
0.757 | Intermediate Similarity | NPD9379 | Approved |
0.757 | Intermediate Similarity | NPD7843 | Approved |
0.757 | Intermediate Similarity | NPD9377 | Approved |
0.757 | Intermediate Similarity | NPD7635 | Approved |
0.7568 | Intermediate Similarity | NPD4093 | Discontinued |
0.7545 | Intermediate Similarity | NPD16 | Approved |
0.7545 | Intermediate Similarity | NPD856 | Approved |
0.7523 | Intermediate Similarity | NPD6671 | Approved |
0.75 | Intermediate Similarity | NPD1751 | Approved |
0.75 | Intermediate Similarity | NPD4589 | Approved |
0.75 | Intermediate Similarity | NPD3019 | Approved |
0.75 | Intermediate Similarity | NPD4059 | Approved |
0.75 | Intermediate Similarity | NPD968 | Approved |
0.75 | Intermediate Similarity | NPD2932 | Approved |
0.75 | Intermediate Similarity | NPD5238 | Clinical (unspecified phase) |
0.7453 | Intermediate Similarity | NPD5451 | Approved |
0.7431 | Intermediate Similarity | NPD475 | Phase 2 |
0.7429 | Intermediate Similarity | NPD9265 | Clinical (unspecified phase) |
0.7391 | Intermediate Similarity | NPD9089 | Approved |
0.7387 | Intermediate Similarity | NPD317 | Approved |
0.7387 | Intermediate Similarity | NPD318 | Approved |
0.7368 | Intermediate Similarity | NPD3092 | Approved |
0.7364 | Intermediate Similarity | NPD7157 | Approved |
0.7297 | Intermediate Similarity | NPD9568 | Approved |
0.7283 | Intermediate Similarity | NPD9093 | Approved |
0.7273 | Intermediate Similarity | NPD1476 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD9614 | Approved |
0.7273 | Intermediate Similarity | NPD9618 | Approved |
0.7264 | Intermediate Similarity | NPD290 | Approved |
0.7257 | Intermediate Similarity | NPD4196 | Clinical (unspecified phase) |
0.7257 | Intermediate Similarity | NPD4235 | Clinical (unspecified phase) |
0.7248 | Intermediate Similarity | NPD5535 | Approved |
0.7241 | Intermediate Similarity | NPD6582 | Phase 2 |
0.7241 | Intermediate Similarity | NPD3600 | Clinical (unspecified phase) |
0.7241 | Intermediate Similarity | NPD4659 | Approved |
0.7241 | Intermediate Similarity | NPD6583 | Phase 3 |
0.7222 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7216 | Intermediate Similarity | NPD9295 | Approved |
0.7193 | Intermediate Similarity | NPD4626 | Approved |
0.7193 | Intermediate Similarity | NPD3095 | Discontinued |
0.7193 | Intermediate Similarity | NPD2668 | Approved |
0.7193 | Intermediate Similarity | NPD2286 | Discontinued |
0.7193 | Intermediate Similarity | NPD2667 | Approved |
0.7182 | Intermediate Similarity | NPD5283 | Phase 1 |
0.717 | Intermediate Similarity | NPD3134 | Approved |
0.7168 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7168 | Intermediate Similarity | NPD1548 | Phase 1 |
0.7168 | Intermediate Similarity | NPD9545 | Approved |
0.7158 | Intermediate Similarity | NPD9073 | Approved |
0.7155 | Intermediate Similarity | NPD2562 | Approved |
0.7155 | Intermediate Similarity | NPD2561 | Approved |
0.713 | Intermediate Similarity | NPD3421 | Phase 3 |
0.713 | Intermediate Similarity | NPD2688 | Clinical (unspecified phase) |
0.713 | Intermediate Similarity | NPD3143 | Discontinued |
0.713 | Intermediate Similarity | NPD3847 | Discontinued |
0.7119 | Intermediate Similarity | NPD1134 | Approved |
0.7119 | Intermediate Similarity | NPD1133 | Approved |
0.7119 | Intermediate Similarity | NPD4339 | Clinical (unspecified phase) |
0.7119 | Intermediate Similarity | NPD1129 | Approved |
0.7119 | Intermediate Similarity | NPD4104 | Clinical (unspecified phase) |
0.7119 | Intermediate Similarity | NPD1131 | Approved |
0.7119 | Intermediate Similarity | NPD1135 | Approved |
0.7119 | Intermediate Similarity | NPD3094 | Phase 2 |
0.7119 | Intermediate Similarity | NPD4103 | Phase 2 |
0.7115 | Intermediate Similarity | NPD4818 | Approved |
0.7115 | Intermediate Similarity | NPD4817 | Approved |
0.7103 | Intermediate Similarity | NPD1358 | Approved |
0.708 | Intermediate Similarity | NPD9613 | Approved |
0.708 | Intermediate Similarity | NPD9616 | Approved |
0.708 | Intermediate Similarity | NPD9615 | Approved |
0.7069 | Intermediate Similarity | NPD1610 | Phase 2 |
0.7069 | Intermediate Similarity | NPD422 | Phase 1 |
0.7069 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.7069 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD2195 | Approved |
0.7059 | Intermediate Similarity | NPD2194 | Approved |
0.7059 | Intermediate Similarity | NPD6584 | Phase 3 |
0.7048 | Intermediate Similarity | NPD5700 | Clinical (unspecified phase) |
0.7043 | Intermediate Similarity | NPD9381 | Approved |
0.7043 | Intermediate Similarity | NPD9384 | Approved |
0.7037 | Intermediate Similarity | NPD9266 | Approved |
0.7037 | Intermediate Similarity | NPD74 | Approved |
0.7019 | Intermediate Similarity | NPD1616 | Discontinued |
0.7018 | Intermediate Similarity | NPD7330 | Discontinued |
0.7018 | Intermediate Similarity | NPD316 | Approved |
0.7018 | Intermediate Similarity | NPD1759 | Phase 1 |
0.7009 | Intermediate Similarity | NPD3070 | Discontinued |
0.7 | Intermediate Similarity | NPD5736 | Approved |
0.7 | Intermediate Similarity | NPD159 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD3637 | Approved |
0.7 | Intermediate Similarity | NPD3635 | Approved |
0.7 | Intermediate Similarity | NPD3636 | Approved |
0.6991 | Remote Similarity | NPD3596 | Phase 2 |
0.6991 | Remote Similarity | NPD9493 | Approved |
0.6991 | Remote Similarity | NPD7325 | Clinical (unspecified phase) |
0.699 | Remote Similarity | NPD9611 | Approved |
0.699 | Remote Similarity | NPD9609 | Approved |
0.699 | Remote Similarity | NPD9612 | Approved |
0.6975 | Remote Similarity | NPD3053 | Approved |
0.6975 | Remote Similarity | NPD3055 | Approved |
0.6957 | Remote Similarity | NPD1357 | Approved |
0.6952 | Remote Similarity | NPD855 | Approved |
0.6952 | Remote Similarity | NPD854 | Approved |
0.6949 | Remote Similarity | NPD1755 | Approved |
0.6949 | Remote Similarity | NPD3685 | Discontinued |
0.6949 | Remote Similarity | NPD9622 | Approved |
0.6944 | Remote Similarity | NPD9267 | Approved |
0.6944 | Remote Similarity | NPD9264 | Approved |
0.6944 | Remote Similarity | NPD9263 | Approved |
0.6942 | Remote Similarity | NPD2606 | Approved |
0.6942 | Remote Similarity | NPD4908 | Phase 1 |
0.6942 | Remote Similarity | NPD2605 | Approved |
0.6939 | Remote Similarity | NPD1101 | Approved |
0.6939 | Remote Similarity | NPD9094 | Approved |
0.6937 | Remote Similarity | NPD1138 | Approved |
0.693 | Remote Similarity | NPD1758 | Phase 1 |
0.6923 | Remote Similarity | NPD1535 | Discovery |
0.6917 | Remote Similarity | NPD7451 | Discontinued |
0.6917 | Remote Similarity | NPD257 | Approved |
0.6917 | Remote Similarity | NPD258 | Approved |
0.6897 | Remote Similarity | NPD6516 | Phase 2 |
0.6897 | Remote Similarity | NPD5846 | Approved |
0.6891 | Remote Similarity | NPD5311 | Approved |
0.6891 | Remote Similarity | NPD5310 | Approved |
0.6891 | Remote Similarity | NPD9634 | Clinical (unspecified phase) |
0.6887 | Remote Similarity | NPD4229 | Approved |
0.6887 | Remote Similarity | NPD4656 | Approved |
0.6887 | Remote Similarity | NPD3680 | Approved |
0.6887 | Remote Similarity | NPD4231 | Approved |
0.6887 | Remote Similarity | NPD4658 | Approved |
0.6887 | Remote Similarity | NPD3682 | Approved |
0.6887 | Remote Similarity | NPD3683 | Approved |
0.6887 | Remote Similarity | NPD3681 | Approved |
0.6885 | Remote Similarity | NPD5156 | Approved |
0.6885 | Remote Similarity | NPD3027 | Phase 3 |
0.6885 | Remote Similarity | NPD5155 | Approved |
0.6875 | Remote Similarity | NPD1241 | Discontinued |
0.687 | Remote Similarity | NPD6580 | Approved |
0.687 | Remote Similarity | NPD6581 | Approved |
0.6869 | Remote Similarity | NPD800 | Approved |
0.6864 | Remote Similarity | NPD2232 | Approved |
0.6864 | Remote Similarity | NPD2230 | Approved |
0.6864 | Remote Similarity | NPD1481 | Phase 2 |
0.6864 | Remote Similarity | NPD2233 | Approved |
0.6863 | Remote Similarity | NPD9296 | Approved |
0.686 | Remote Similarity | NPD2861 | Phase 2 |
0.6847 | Remote Similarity | NPD1139 | Approved |
0.6847 | Remote Similarity | NPD1137 | Approved |
0.6842 | Remote Similarity | NPD7636 | Approved |
0.6842 | Remote Similarity | NPD405 | Clinical (unspecified phase) |
0.6838 | Remote Similarity | NPD3023 | Approved |
0.6838 | Remote Similarity | NPD3026 | Approved |
0.6833 | Remote Similarity | NPD1164 | Approved |
0.6829 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
PubChem CID   | 15730 |
ChEMBL   | CHEMBL195437 |
ZINC   |
Molecular Weight:   | 206.17 |
ALogP:   | -2.0746 |
MLogP:   | 2.89 |
XLogP:   | 6.35 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 20.23 |
# H-Bond Aceptor:   | 0 |
# H-Bond Donor:   | 1 |
# Rings:   | 1 |
# Heavy Atoms:   | 15 |